Option Care Health OPCH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Option Care Health (OPCH) Core Market Data and Business Metrics
Latest Closing Price
$34.79Price-Earnings Ratio
28.28Total Outstanding Shares
164.24 Million SharesDividend
No dividendSIC Description
Services-home Health Care ServicesPrimary Exchange
NASDAQHeadquarters
3000 Lakeside Dr, Bannockburn, IL, 60015
Historical Stock Splits
If you bought 4 shares of OPCH before February 3, 2020, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| February 3, 2020 | 1-for-4 (Reverse Split) |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 2,093,719 Shares | 1.95 | 3/14/2025 | 4,081,614 Shares |
| 1,911,643 Shares | 1.93 | 2/28/2025 | 3,680,439 Shares |
| 1,220,235 Shares | 3.2 | 2/14/2025 | 3,910,397 Shares |
| 1,767,031 Shares | 2.04 | 1/31/2025 | 3,609,104 Shares |
| 2,295,338 Shares | 1.86 | 1/15/2025 | 4,280,711 Shares |
| 1,826,302 Shares | 2.08 | 12/31/2024 | 3,797,011 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities | $323.39 Million |
| Net Cash Flow From Operating Activities, Continuing | $323.39 Million |
| Net Cash Flow From Investing Activities | $-36.47 Million |
| Net Cash Flow From Financing Activities | $-218.21 Million |
| Net Cash Flow | $68.72 Million |
| Net Cash Flow, Continuing | $68.72 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Diluted Average Shares | $172.84 Million |
| Selling, General, and Administrative Expenses | $630.25 Million |
| Gross Profit | $1.01 Billion |
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Income/Loss From Continuing Operations Before Tax | $283.60 Million |
| Income/Loss From Equity Method Investments | $5.96 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $207.89 Million |
| Other Comprehensive Income/Loss | $207.89 Million |
| Comprehensive Income/Loss Attributable To Parent | $207.89 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss Attributable To Parent | $-3.93 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Long-term Debt | $1.11 Billion |
| Equity | $1.40 Billion |
| Accounts Payable | $610.78 Million |
| Other Current Liabilities | $106.34 Million |
| Other Non-current Liabilities | $126.21 Million |
| Current Assets | $1.32 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||